Protective role of Ipomoea obscura (L.) on cyclophosphamide-induced uro- And nephrotoxicities by modulating antioxidant status and pro-inflammatory cytokine levels

Inflammopharmacology

Volumn 19, Issue 3, 2011, Pages 155-167

  Hamsa, T P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Cyclophosphamide; Ipomoea obscura; Nephrotoxicity; Proinflammatory cytokine; Urotoxicity

Indexed keywords

ALKYLATING AGENT; ANTIOXIDANT; AUTACOID; CREATININE; CYCLOPHOSPHAMIDE; CYTOKINE; PLANT EXTRACT;

ANIMAL; ARTICLE; BLADDER DISEASE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; IPOMOEA; KIDNEY DISEASE; MALE; METABOLISM; MOUSE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; BLOOD UREA NITROGEN; BODY WEIGHT; CREATININE; CYCLOPHOSPHAMIDE; CYTOKINES; INFLAMMATION MEDIATORS; IPOMOEA; KIDNEY DISEASES; MALE; MICE; PLANT EXTRACTS; URINARY BLADDER DISEASES;

EID: 80755175634     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-010-0055-3     Document Type: Article

References (48)

1. Abraham P, Sugumar E (2008) Increased glutathione levels and activity of phenyl acetate esterase (PON1) in the liver of rats after a single dose of cyclophosphamide: a defense mechanism? Exp Toxicol Pathol 59:301-306 (Pubitemid 351288525)
2. Aebi H (1974) Catalase estimation. In: Berg Meyer HV, Verlag C (eds) Methods of enzymatic analysis. Chemie/Academic Press, New York, pp 673-68
3. Ajith TA, Nivitha V, Usha S (2007) Zingiber officinale Roscoe alone and in combination with a-tocopherol protect the kidney against cisplatin-induced acute renal failure. Food Chem Toxicol 45:921-927 (Pubitemid 46507684)
4. Anderson PM, Sorenson MA (1994) Effects of route and formulation on clinical pharmacokinetics of interleukin-2. Clin Pharmacokinet 1:19-31 (Pubitemid 24211094)
5. Atessahin A, Karahan I, Yilmaz S, Ceribasi AO, Pirincci I (2003) The effect of manganese chloride on gentamicine-induced nephrotoxicity in rats. Pharmacol Res 48:637-642 (Pubitemid 38352783)
6. Balkwill FR (1989) Interferons. Lancet 13:1060-1063
7. Bhatia K, Kaur M, Atif F, Ali M, Rehman H, Rahman S, Raisuddin S (2006) Aqueous extract of Trigonella foenum-graecum L. ameliorates additive urotoxicity of hionine sulfoximine and cyclophosphamide in mice. Food Chemic Toxicol 44:1744-1750 (Pubitemid 44216083)
8. Bhatia K, Ahmad F, Rashid H, Raisuddin S (2008) Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice. Food Chem Toxicol 46(11):3368-3374
9. Brock N, Pohl J (1986) Prevention of urotoxic side effects by regional detoxification with increased selectivity of xazaphosphorine cytostatics. Int Agency Res Cancer Sci Publ 78:269-279
10. Cagler K, Kinalp C, Arpaci F, Turan M, Saglam K, Ozturk B, Komurcu S, Yavuz I, Yenicesu M, Ozet A, Vural A (2002) Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation. Nephr Dial Transpl 17:1931-1935 (Pubitemid 35277090)
11. Cavalletti E, Tofanetti O, Zunino F (1986) Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclo-phosphamide-induced urotoxicity. Cancer Lett 32:1-6 (Pubitemid 16040825)
12. Cerutti P, Ghosh R, Oya Y, Amstad P (1994) The role of cellular antioxidant defense in oxidant carcinogenesis. Environ Health Perspect 102:123-129
13. Cetin R, Devrim E, Kilicoglu B, Avei A, Candir O, Durak I (2006) Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J Appl Toxicol 26:42-46 (Pubitemid 43171334)
14. Collins A, Duthie S, Ross M (1994) Micronutrients and oxidative stress in the aetiology of cancer. Proc Nutr Soc 53:67-75
15. Dechant KL, Brogden RN, Pilkington T (1991) Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 42:428
16. Egido JM, Gomez-Chiarri A, Ortiz C, Bustos J, Alonso C, Gomez-Guerrero D, Gomez-Garre MJ, Lopez-Armada J, Plaza G (1993) Role of tumor necrosisfactor-α in the pathogenesis of glomerular diseases. Kidney Int 39:59-64
17. Fosberg FR, Sachet MH (1977) Convolvulaceae. Flora of Micronesia, 3. Smithsonian Contrib Bot 36:1-3
18. Giroir BP, John JH, Brown T, Allen GL, Beutler B (1992) The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. Brett J Clin Invest 90:693-698
19. Hafemann DG, Sunde RA, Houestra WG (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 104:580-584
20. Halliwell B, Cross CE (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102:5-12
21. Hamsa TP, Kuttan G (2009) Ipomoea obscura (L.) enhances the functions of immunological effector cells inhibits proinflammatory cytokines and nitric oxide production by LPS induced macrophages. Immunopharmacol Immunotoxicol 31:222-229
22. Haque R, Bin-Hafeez B, Ahmad, Parvez S, Pandey S, Raisuddin S (2001) Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol 20:643-650
23. Hung YC, Huang GS, Lin LW, Hong MY (2007) Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice. Food ChemToxicol 45:1123-1130 (Pubitemid 46590553)
24. Hutter AM, Bauman AW, Frank IN (1969) Cyclophosphamide and severe haemarragic cystitis. NY State J Med 69:305-309
25. Jenett-Siems K, Weigl R, Kaloga M, Schulz J, Eich E (2003) Ipobscurines C and D: macrolactam-type indole alkaloids from the seeds of Ipomoea obscura. Phytochem 62(8):1257-1263 (Pubitemid 36383598)
26. Kehrer JP, Biswal SS (2000) The molecular effects of acrolein. Toxicol Sci 57:6-15
27. Kirtikar KR, Basu BD (1980). In: Singh MP, Singh BP (eds) Indian medicinal plants, 2nd ed, p 902
28. Lavin P, Koss LG (1971) Effects of a single dose of cyclophosphamide on various organs in the rat. IV: electron microscopic study of the renal tubules. Am J Pathol 162:169-175
29. Mc Cord JM, Fridovich I (1969) Superoxide dismutase, an enzymatic function for erythrocuprein. J Biol Chem 244:6049-6055
30. Michael B, Atkins, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Terry P (2001) A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. Clin Cancer Res 7:486-492
31. Mohrmann M, Ansorge S, Schmich U, Schonfeld B, Brandis M (1994) Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr Nephrol 8:157-163 (Pubitemid 24092249)
32. Moron MA, Depierre JW, Mannervick B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78 (Pubitemid 9065588)
33. Muhl H, Pfeilschifter J (2003) Anti-inflammatory properties of proinflammatory interferon-c. Intern Immunopharmacol 3:1247-1255
34. Ohkawa H, Oshishi N, Yagi K (1979) Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (Pubitemid 9194347)
35. Oriana S, Bohm S, Spatti G, Zunino F (1987) A preliminary clinical experiment with reduced glutathione as a protector against cisplatin-toxicity. Tumori 73:337-340 (Pubitemid 17158350)
36. Ormstad K, Ohno Y (1984) N-acetylcycteine and sodium 2-mercaptoethane sulfonate as a source of urinary thiol groups in the rat. Cancer Res 44:3797-3800 (Pubitemid 14041593)
37. Patel JM (1987) Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicology 45:79-91
38. Paula ACB, Hayashi LSS, Freitas JC (2003) Anti-inflammatory and antispasmodic activity of Ipomoea imperati (Vahl) Griseb (Convolvulaceae). Braz J Med Biol Res 36(1):105-112 (Pubitemid 36231199)
39. Pongprayoon U, Baeckstrom P, Jacobsson U, Linstrom M, Bohlin C (1992) Antispasmodic activity of beta-damascenone and Ephytol isolated from Ipomoea pescaprae. Planta Med 58:19-21
40. Raymond JR (1984) Nephrotoxicities of antineoplastic and immunosuppressive agents. Curr Probl Cancer 8(16):1-32
41. Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueiredo FC, Brito GAC, Cunha FQ (2002) Tumor necrosis factor- and interleukin-1 mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 167:2229-2234 (Pubitemid 34309711)
42. Sulkowska M, Sulkowski S, Skrzydlewska E, Farbiszewski R (1998) Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries. Exp Toxicol Pathol 50:209-220 (Pubitemid 28293903)
43. Verley H (1980) Practical clinical biochemistry, 5th edn. William Hieneman medical Books Ltd, London, pp 550-555
44. Vielhauer V, Mayadas TN (2007) Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 27(3):286-308 (Pubitemid 46802916)
45. Werts ED, Gould MN (1986) Relationships between cellular superoxide dismutase and susceptibility to chemically induced cancer in the rat mammary gland. Carcinogen 7:1197-1201 (Pubitemid 17123010)
46. Wood R, Eichel L, Messing EM, Schwarz E (2001) Automated noninvasive measurement of cyclophosphamide-induced changes in murine micturition frequency and volume and demonstration of pharmacologic sensitivity. Urology 57:115-116
47. Wybenga DR, Giorgio JD, Pileggi VJ (1971) Manual and automated methods for urea nitrogen measurement in whole Serum. Clin Chem 17:891-895
48. Zhang J, Tian Q, Chan SY, Duan W, Zhou SF (2006) Clinical pharmacology of cyclophosphamide and ifosfamide. Curr Drug Ther 1:55-84